Partnership Will Support Collaboration on Health Science Research During COVID-19
December 15th 2020Pharmacy Times® interviewed Signe Pringle, the assistant secretary for the Maryland Department of Commerce, on a signed partnership between Quebec and Maryland to foster collaboration around health science research during COVID-19 and beyond.
Watch
Pharmacists Can Preemptively Educate Patients on the Process for Receiving a COVID-19 Vaccine
December 7th 2020In an interview with Pharmacy Times, Stefan Behrens, PhD, CEO and co-founder of GYANT, and Justin Graham, MD, MS, chief medical officer, said preparing patients for the process of receiving a coronavirus disease 2019 (COVID-19) vaccine is essential.
Watch
Dosing Patients with Kidney Disease Presents Unique Challenges
December 1st 2020In an interview with Pharmacy Times, Bruce Mueller, PharmD, interim dean and professor of clinical pharmacy at the University of Michigan College of Pharmacy, said pharmacists are essential in providing the correct dosing to patients with kidney disease.
Watch
Strategies for Encouraging Collaboration in Clinical Decision Making
November 24th 2020In an interview with Pharmacy Times, Peter Bonis, MD, chief medical officer of clinical effectiveness at Wolters Kluwer Health, said collaboration between pharmacists, physicians, and other health care workers is essential.
Watch
Pediatricians Express Concerns About HHS Authorization of Pharmacists to Deliver Childhood Vaccines
November 19th 2020In a discussion with Pharmacy Times, Susan DiGregorio, BS Pharm, MS, RPh, director of clinical pharmacy development at Community Care Rx, said that collaborating with pediatricians and other health care providers is essential for pharmacists to effectively administer vaccines to children.
Watch
More Than 500 Therapeutics Being Investigated for COVID-19
November 19th 2020Pharmacy Times spoke with Michael Haydock, senior director of content for cardiovascular, metabolic, and infectious diseases at Informa Pharma Intelligence, about investigational therapeutics for COVID-19 and what’s in the pipeline.
Watch
The Work of the COVID-19 and Cancer Consortium During the COVID-19 Pandemic
November 10th 2020Pharmacy Times® interviewed Petros Grivas, MD, PhD, associate professor at the University of Washington and Fred Hutchinson Cancer Research Center and a medical oncologist at Seattle Cancer Care Alliance, on the work of the COVID-19 and Cancer Consortium.
Watch
How Using Social Determinants of Health in Tandem With Clinical Data Can Benefit Pharmacies
November 6th 2020Pharmacy Times® interviewed Rich Morino, senior director of health care solutions at LexisNexis, on how using social determinants of health in tandem with clinical data can benefit pharmacies.
Watch
How Federal and State Law May Affect Vaccine Administration During the COVID-19 Pandemic
November 4th 2020Pharmacy Times® interviewed Ned Milenkovich, PharmD, JD, principal and co-chair of the Health Care Law practice group at Much Shelist, on how federal and state law may affect vaccine administration in accordance with recent HHS declarations.
Watch
Supporting Economic Growth Among Community, Retail Pharmacies During the COVID-19 Pandemic
October 29th 2020Pharmacy Times® interviewed Maryland Secretary of Commerce Kelly M. Schulz on how growth in the health care and biotech industry can support economic revitalization during and following the COVID-19 pandemic among community and retail pharmacies.
Watch
The Value of the Pharmacist in the Treatment of Patients With Cancer During the COVID-19 Pandemic
October 16th 2020Pharmacy Times® interviewed Petros Grivas, associate professor at the University of Washington and Fred Hutchinson Cancer Research Center and a medical oncologist at Seattle Cancer Care Alliance, on the value of the pharmacist in the treatment of patients with cancer during COVID-19.
Watch
The Value of the Pharmacist as a First Line of Defense During the COVID-19 Pandemic
October 15th 2020Pharmacy Times® interviewed Ned Milenkovich, PharmD, JD, principal and co-chair of the Health Care Law practice group at Much Shelist, on the value of the pharmacist during the flu season and concurrent COVID-19 pandemic this year.
Watch